Global Veterinary Injectable Devices Market Outlook 2030

A veterinary injectable device provides a handy alternative to orally administered drugs. The active substance is injected into the animal's bloodstream, promptly transported to the rest of the body. In the recent years various types of advanced injectable devices are developed in order to eliminate the existing devices difficulty and provide ease in treatment process. A syringe, needles, remote drug delivery systems, needle-free injection systems, and other veterinary injectable devices are included. The global veterinary injectable devices market is anticipated to grow with a CAGR of 4.69% over the forecast period, i.e., 2021 - 2030. Factors such as growing expenditure on pets, followed by the rising adoption of companion animals, increasing concern for different types of animal diseases, and the need for timely vaccinations of these animals, are anticipated to drive the market growth. The market is estimated to garner a revenue of close to USD 1400 Million by the end of 2030, up from a revenue of about USD 890 Million in the year 2020.

The global veterinary injectable devices market is segmented into numerous segments, which include segmentation by product, usability, materials, end-user, and by region. On the basis of material, the market is divided into glass, metal, plastic, and others, out of which, the plastic segment generated the largest revenue of around USD 460 Million in the year 2020, and is further expected to hold the largest revenue of over USD 710 Million by the end of 2030, by growing with a CAGR of 5% approximately during the forecast period.

The global veterinary injectable devices market is segmented on the basis of region into North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these regions, the market in North America region is expected to generate the largest revenue of about USD 470 Million by the end of 2030, up from a revenue of near to USD 300 Million in the year 2020.

Some of the prominent industry leaders in the global veterinary injectable devices market that are included in our report are Boehringer Ingelheim International GmbH, Henke-Sass, Wolf GmbH, TeleDart USA, H. Hauptner and Richard Herberholz GmbH & Co. KG, Schippers Export BV, Hamilton Company, Merck & Co., Inc. (Allflex), NEOGEN Corporation, Terumo Medical Corporation, Quick Shot Corporation, and others.